Literature DB >> 33383855

Gender Differences and Quality of Life in Parkinson's Disease.

Pietro Crispino1, Miriam Gino2, Elena Barbagelata3, Tiziana Ciarambino4, Cecilia Politi5, Immacolata Ambrosino6, Rosalia Ragusa7, Marina Marranzano8, Antonio Biondi9, Marco Vacante9.   

Abstract

Parkinson's disease has been found to significantly affect health-related quality of life. The gender differences of the health-related quality of life of subjects with Parkinson's disease have been observed in a number of studies. These differences have been reported in terms of the age at onset, clinical manifestations, and response to therapy. In general, women with Parkinson's disease showed more positive disease outcomes with regard to emotion processing, non-motor symptoms, and cognitive functions, although women report more Parkinson's disease-related clinical manifestations. Female gender predicted poor physical functioning and socioemotional health-related quality of life, while male gender predicted the cognitive domain of health-related quality of life. Some studies reported gender differences in the association between health-related quality of life and non-motor symptoms. Depression and fatigue were the main causes of poorer health-related quality of life in women, even in the early stages of Parkinson's disease. The aim of this review was to collect the best available evidence on gender differences in the development of Parkinson's disease symptoms and health-related quality of life.

Entities:  

Keywords:  Parkinson’s disease; dopamine; gender; levodopa; quality of life

Mesh:

Year:  2020        PMID: 33383855      PMCID: PMC7795924          DOI: 10.3390/ijerph18010198

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  124 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  The implicit sequence learning deficit in patients with Parkinson's disease: a matter of impaired sequence integration?

Authors:  Jared G Smith; John McDowall
Journal:  Neuropsychologia       Date:  2005-06-16       Impact factor: 3.139

3.  Abnormal gaze strategies during problem solving in Parkinson's disease.

Authors:  T L Hodgson; B Tiesman; A M Owen; C Kennard
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

4.  Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups.

Authors:  K Berganzo; B Tijero; A González-Eizaguirre; J Somme; E Lezcano; I Gabilondo; M Fernandez; J J Zarranz; J C Gómez-Esteban
Journal:  Neurologia       Date:  2014-12-17       Impact factor: 3.109

Review 5.  The relevance of gender in Parkinson's disease: a review.

Authors:  Marina Picillo; Alessandra Nicoletti; Vincenza Fetoni; Barbara Garavaglia; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

6.  Gender differences in Parkinson's disease.

Authors:  Charlotte A Haaxma; Bastiaan R Bloem; George F Borm; Wim J G Oyen; Klaus L Leenders; Silvia Eshuis; Jan Booij; Dean E Dluzen; Martin W I M Horstink
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-10       Impact factor: 10.154

7.  Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

Authors:  Simon J G Lewis; Anja Dove; Trevor W Robbins; Roger A Barker; Adrian M Owen
Journal:  J Neurosci       Date:  2003-07-16       Impact factor: 6.167

8.  Gender and onset age-related features of non-motor symptoms of patients with Parkinson's disease--a study from Southwest China.

Authors:  Xiaoyan Guo; Wei Song; Ke Chen; Xueping Chen; Zhenzhen Zheng; Bei Cao; Rui Huang; Bi Zhao; Ying Wu; Hui-Fang Shang
Journal:  Parkinsonism Relat Disord       Date:  2013-07-10       Impact factor: 4.891

Review 9.  Sex differences in Parkinson's disease.

Authors:  Glenda E Gillies; Ilse S Pienaar; Shiv Vohra; Zahi Qamhawi
Journal:  Front Neuroendocrinol       Date:  2014-03-04       Impact factor: 8.606

10.  Factors influencing psychosocial adjustment and quality of life in Parkinson patients and informal caregivers.

Authors:  María Victoria Navarta-Sánchez; Juana M Senosiain García; Mario Riverol; María Eugenia Ursúa Sesma; Sara Díaz de Cerio Ayesa; Sagrario Anaut Bravo; Neus Caparrós Civera; Mari Carmen Portillo
Journal:  Qual Life Res       Date:  2016-01-08       Impact factor: 4.147

View more
  4 in total

Review 1.  Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.

Authors:  Tapan Behl; Piyush Madaan; Aayush Sehgal; Sukhbir Singh; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

2.  Predictors of clinically significant quality of life impairment in Parkinson's disease.

Authors:  Diego Santos García; Teresa de Deus Fonticoba; Carlos Cores; Guillermo Muñoz; Jose M Paz González; Cristina Martínez Miró; Ester Suárez; Silvia Jesús; Miquel Aguilar; Pau Pastor; Lluis Planellas; Marina Cosgaya; Juan García Caldentey; Nuria Caballol; Inés Legarda; Jorge Hernández Vara; Iria Cabo; Luis López Manzanares; Isabel González Aramburu; María A Ávila Rivera; Maria J Catalán; Víctor Nogueira; Víctor Puente; María Ruíz de Arcos; Carmen Borrué; Berta Solano Vila; María Álvarez Sauco; Lydia Vela; Sonia Escalante; Esther Cubo; Francisco Carrillo Padilla; Juan C Martínez Castrillo; Pilar Sánchez Alonso; Maria G Alonso Losada; Nuria López Ariztegui; Itziar Gastón; Pedro Clavero; Jaime Kulisevsky; Marta Blázquez Estrada; Manuel Seijo; Javier Rúiz Martínez; Caridad Valero; Mónica Kurtis; Oriol de Fábregues; Jessica González Ardura; Carlos Ordás; Luis M López Díaz; Darrian McAfee; Pablo Martinez-Martin; Pablo Mir
Journal:  NPJ Parkinsons Dis       Date:  2021-12-16

3.  Efficacy of Safinamide and Gender Differences During Routine Clinical Practice.

Authors:  Maria T Pellecchia; Marina Picillo; Maria C Russillo; Maria F De Pandis; Erminio Bonizzoni; Ivan Marjanovic; Carlo Cattaneo
Journal:  Front Neurol       Date:  2021-12-14       Impact factor: 4.003

4.  Long-term independence and quality of life after subthalamic stimulation in Parkinson disease.

Authors:  Anna Castrioto; Bettina Debû; Emilie Cousin; Pierre Pelissier; Eugénie Lhommée; Amélie Bichon; Emmanuelle Schmitt; Andrea Kistner; Sara Meoni; Eric Seigneuret; Stephan Chabardes; Paul Krack; Elena Moro; Valérie Fraix
Journal:  Eur J Neurol       Date:  2022-06-24       Impact factor: 6.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.